380 related articles for article (PubMed ID: 15988337)
1. [Multisystemic amyloidosis. Clinical study of 39 patients in Lebanon].
Saba M; Tohmé A; Abadjian G; Haddad F; Ghayad E
Presse Med; 2005 May; 34(9):640-6. PubMed ID: 15988337
[TBL] [Abstract][Full Text] [Related]
2. Amyloid storm: acute kidney injury and massive proteinuria, rapidly progressing to end-stage kidney disease in AA amyloidosis of familial Mediterranean fever.
Kukuy OL; Beckerman P; Dinour D; Ben-Zvi I; Livneh A
Rheumatology (Oxford); 2021 Jul; 60(7):3235-3242. PubMed ID: 33291151
[TBL] [Abstract][Full Text] [Related]
3. Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience.
Ozawa M; Komatsuda A; Ohtani H; Nara M; Sato R; Togashi M; Takahashi N; Wakui H
Clin Exp Nephrol; 2017 Apr; 21(2):212-227. PubMed ID: 27116248
[TBL] [Abstract][Full Text] [Related]
4. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
[TBL] [Abstract][Full Text] [Related]
5. AA amyloidosis complicating the hereditary periodic fever syndromes.
Lane T; Loeffler JM; Rowczenio DM; Gilbertson JA; Bybee A; Russell TL; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ
Arthritis Rheum; 2013 Apr; 65(4):1116-21. PubMed ID: 23280696
[TBL] [Abstract][Full Text] [Related]
6. Head and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases.
Gouvêa AF; Ribeiro AC; León JE; Carlos R; de Almeida OP; Lopes MA
J Oral Pathol Med; 2012 Feb; 41(2):178-85. PubMed ID: 21883489
[TBL] [Abstract][Full Text] [Related]
7. Incidence and clinical outcome of renal amyloidosis: a retrospective study.
Abdallah E; Waked E
Saudi J Kidney Dis Transpl; 2013 Sep; 24(5):950-8. PubMed ID: 24029260
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes and survival in AA amyloidosis patients.
Ayar Y; Ersoy A; Oksuz MF; Ocakoglu G; Vuruskan BA; Yildiz A; Isiktas E; Oruc A; Celikci S; Arslan I; Sahin AB; Güllülü M
Rev Bras Reumatol Engl Ed; 2017; 57(6):535-544. PubMed ID: 29173691
[TBL] [Abstract][Full Text] [Related]
9. [Amyloidosis. II. Current pathogenetic and clinico-nosographic aspects].
Lovisetto P; Frascisco M; Gilardi E; Marchi L; Mairano D
Minerva Med; 1980 Jun; 71(25):1801-13. PubMed ID: 6774298
[TBL] [Abstract][Full Text] [Related]
10. Familial Mediterranean fever (FMF) with proteinuria: clinical features, histology, predictors, and prognosis in a cohort of 25 patients.
Kukuy O; Livneh A; Ben-David A; Kopolovic J; Volkov A; Shinar Y; Holtzman E; Dinour D; Ben-Zvi I
J Rheumatol; 2013 Dec; 40(12):2083-7. PubMed ID: 24128782
[TBL] [Abstract][Full Text] [Related]
11. Predictors of AA amyloidosis in familial Mediterranean fever.
Mukhin NA; Kozlovskaya LV; Bogdanova MV; Rameev VV; Moiseev SV; Simonyan AKh
Rheumatol Int; 2015 Jul; 35(7):1257-61. PubMed ID: 25586652
[TBL] [Abstract][Full Text] [Related]
12. AA protein in a case of "primary" or "idiopathic" amyloidosis.
Pras M; Zaretzky J; Frangione B; Franklin EC
Am J Med; 1980 Feb; 68(2):291-4. PubMed ID: 6766664
[TBL] [Abstract][Full Text] [Related]
13. Amyloidosis: review of 236 cases.
Kyle RA; Bayrd ED
Medicine (Baltimore); 1975 Jul; 54(4):271-99. PubMed ID: 1152671
[TBL] [Abstract][Full Text] [Related]
14. Protein AA in primary and myeloma associated amyloidosis.
Falck HM; Westermark P
Clin Exp Immunol; 1983 Oct; 54(1):259-64. PubMed ID: 6413109
[TBL] [Abstract][Full Text] [Related]
15. Clinical and laboratory profile of renal amyloidosis: A single-center experience.
Engineer DP; Kute VB; Patel HV; Shah PR
Saudi J Kidney Dis Transpl; 2018; 29(5):1065-1072. PubMed ID: 30381502
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and immunohistochemical classification of systemic amyloidoses. Report of 43 cases in an unselected autopsy series.
Strege RJ; Saeger W; Linke RP
Virchows Arch; 1998 Jul; 433(1):19-27. PubMed ID: 9692821
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
Varan Ö; Kucuk H; Babaoglu H; Guven SC; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
Mod Rheumatol; 2019 Mar; 29(2):363-366. PubMed ID: 29578360
[TBL] [Abstract][Full Text] [Related]
18. French practical guidelines for the diagnosis and management of AA amyloidosis.
Georgin-Lavialle S; Savey L; Buob D; Bastard JP; Fellahi S; Karras A; Boffa JJ; Grateau G; ; Audard V; Bridoux F; Damade R; Deshayes S; Giurgea I; Granel B; Hachulla E; Hot A; Jaccard A; Knebelmann B; Marciano S; Pelcot F; Sarrabay G; Boursier G; Sellam J; Terre A; Bourguiba R
Rev Med Interne; 2023 Feb; 44(2):62-71. PubMed ID: 36759076
[TBL] [Abstract][Full Text] [Related]
19. Remission of proteinuria and preservation of renal function in patients with renal AA amyloidosis secondary to rheumatoid arthritis.
Ueno T; Takeda K; Nagata M
Nephrol Dial Transplant; 2012 Feb; 27(2):633-9. PubMed ID: 21771754
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and epidemiological analysis of amyloidosis in Turkish patients.
Ensari C; Ensari A; Tümer N; Ertug E
Nephrol Dial Transplant; 2005 Aug; 20(8):1721-5. PubMed ID: 15972323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
